1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Kontour (Xi'an) Medical Technology Co., Ltd. Class A

Kontour (Xi'an) Medical Technology Co., Ltd. Class A

SSSE:688314
27.77
CNY
+0.72
(+2.66%)
1.14EPS
29.30P/E
2.75BMarket Cap
Kontour (Xi'an) Medical Technology Co., Ltd. Class A
SSE:688314
(Shanghai Stock Exchange)

Recent

price

27.77

P/E

ratio

29.30

div

yld

1.89%

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.24
1.84
2.48
2.68
2.92
2.95
3.39
3.97
4.3
4.4
Revenue per Share
0.17
0.37
0.87
0.86
1.12
0.93
0.93
1.09
1.21
1.16
Basic EPS, GAAP
0.18
0.31
0.81
-0.25
0.66
0.91
0.87
1.14
0.82
- -
Free Cash Flow per Basic Share
- -
- -
0.01
0.01
0.42
0.45
0.39
0.53
0.4
0.53
Dividend per Share
1.64
2.07
3.16
4.01
6.2
6.69
7.23
7.82
8.84
9.18
Book Value per Share
1.18
1.64
2.78
3.52
5.87
6.39
6.97
7.41
7.25
7.65
Tangible Book Value per Share
59
60
60
61
73
81
81
81
82
82
Basic Weighted Avg Shares
72
110
148
164
213
240
275
322
351
359
Sales/Revenue/Turnover
17.58
22.72
41.26
32.83
41.09
35.45
35.89
37.87
35.77
32.02
Operating Margin (%)
3
6
6
6
11
12
12
14
16
- -
Depreciation Expense
10
22
52
52
82
76
76
88
99
94
Net Income, GAAP
17.79
12.12
15.87
12.19
14.9
16.17
18.83
17.33
15.38
14.05
Effective Tax Rate (%)
13.88
20.23
35.14
31.93
38.4
31.54
27.46
27.46
28.11
26.29
Profit Margin (%)
51
64
139
102
314
317
347
324
338
342
Working Capital
- -
4
- -
4
3
2
1
7
41
48
LT Debt
102
127
192
243
501
542
586
638
724
753
Total Equity
- -
17.41
30.11
19.26
18.33
12.81
12.09
13.22
12.41
11.31
Return on Invested Capital (%)
- -
19.73
32.21
23.21
20.97
14.16
12.96
13.91
13.6
12.61
Return on Capital (%)
- -
19.6
32.58
23.96
21.83
14.46
13.36
14.46
14.59
13.43
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
47
47
47
LT Borrowings
34
33
42
LT Finance Leases
7
6
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
81
81
81
Market Capitalization
2,686
4,055
2,752

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
443
429
443
Cash, Cash Equivalents & STI
374
359
373
Accounts Receivable, Net
18
12
11
Inventories
33
38
39
Total Current Liabilities
105
99
102
Payables & Accruals
- -
- -
- -
ST Debt
47
47
47
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
28.97%
13.51%
Free Cash Flow
- -
-72.97%
-28.22%
Net Income, GAAP
- -
15.41%
11.66%
Sales/Revenue/Turnover
- -
16.63%
9.05%
Total Cash Common Dividend
- -
1,837.61%
-23.23%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70
83
87
82
322
2025
82
88
- -
100
351
2026
74
97
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
0.36
0.34
0.14
1.09
2025
0.3
0.38
- -
0.27
1.21
2026
0.16
0.35
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.33
0.01
0.19
0.53
2025
0.01
0.19
- -
0.01
0.4
2026
0.01
0.33
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Kontour (Xi'an) Medical Technology Co., Ltd. Kontour (Xi'an) Medical Technology Co., Ltd. (688314.SS) is a China-based high-tech enterprise engaged in the research, development, production, and sales of Class III implantable medical devices. The company offers a comprehensive portfolio of products including titanium and poly-ether-ether-ketone (PEEK) skull repair and fixation systems such as PEEK bone plates, titanium mesh plates, PEEK link plates, titanium link plates, screws, trial molds, bone plugs, bone mesh, and bone plug strips; sternum fixation products for cardiothoracic surgery; maxillofacial repair solutions; neurospine products; disposable brain drainage devices; dental implants, implant guides, titanium mesh, GBR series nails, dental tool boxes, and related surgical auxiliary instruments; as well as supporting surgical tools. These products serve neurosurgery cranial repair and fixation, cardiothoracic surgery sternal fixation, maxillofacial repair, stomatology, and related fields, with distribution in domestic Chinese markets and overseas. Founded in 2005 and headquartered in Xi'an, Shaanxi Province, China, the company operates primarily in the medical devices sector, targeting hospitals, surgeons, and healthcare providers with advanced CAD/CAM and 3D printing technologies for precision-engineered implants. It holds over 30 international patents across three continents and maintains ISO certification, emphasizing patient-specific solutions, bioadaptive materials, and AI-enhanced surgical planning. In recent developments, Kontour (Xi'an) Medical Technology released its fiscal 2025 third quarter earnings on October 27, 2025, reporting revenue of CNY 80.77 million and earnings per share of CNY 0.2614, reflecting ongoing operational performance amid a net profit attributable to the parent of CNY 76.72 million for the first three quarters. The company continues to pursue strategic partnerships with leading medical institutions to advance next-generation implant technologies and clinician training programs, while participating in global events such as WHX Miami 2025 to expand its network. No major acquisitions, funding rounds, or name changes have been reported in the last 1-2 years, with focus remaining on R&D innovation and domestic market strengthening.